ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
39 announcements with these filters
Zim Laboratories Ltd reported revenue from operations of ₹105.3 Cr (-3.1% YoY) and net profit of ₹3.7 Cr (-24.5% YoY) for Q4 FY26.
Zim Laboratories reported annual consolidated total income of ₹385.78 Crore for FY26. The Board also appointed M/s Dhananjay V. Joshi & Associates as Cost Auditors.
Zim Laboratories scheduled a board meeting for May 19, 2026, to approve audited financial results. The trading window remains closed until May 21, 2026.
Zim Laboratories granted 1,29,200 stock options at Rs. 77.40 each, totaling ₹1.00 Crore. This employee incentive scheme supports long-term talent retention and alignment.
ZIM Laboratories completed an EU GMP inspection by German and Portuguese authorities at its Nagpur facility. No adverse observations were reported, maintaining regulatory compliance standards.
Zim Laboratories Limited has allotted 48,726 equity shares under its ESOP/ESPS scheme on April 18, 2026. This allotment increases the company's total paid-up share capital from ₹53.50 Crore to ₹53.55 Crore.
ZIM Laboratories Limited allotted 48,726 equity shares to a subsidiary employee under its ESOS 2023 scheme. The allotment, valued at ₹0.38 Crore, increases the company's paid-up capital to ₹53.55 Crore. The new shares rank pari-passu with existing equity.
ZIM Laboratories Limited has invested Rs. 0.89 Crore (AUD 1,35,000) into its subsidiary ZIMTAS Pty Ltd. This investment is part of a total approved amount of up to Rs. 2 Crore for equity shares in the subsidiary.
Zim Laboratories Limited invested ₹0.89 Crore (AUD 1,35,000) into the equity shares of its subsidiary, ZIMTAS Pty Ltd. Following this investment, the company now holds 99.96% of the subsidiary's total share capital. This move follows an approved investment limit of up to ₹2.00 Crore.